Evidence map›Paper›PMID 40916442›Full record

ArticleTurkish journal of pharmaceutical sciences2025

Comparison of In Vitro and

Ayşe Nur Oktay, James E Polli

Abstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ayşe Nur OktayUniversity of Health Sciences Türkiye Gülhane Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye.ORCID 0000-0002-6465-6450
James E PolliUniversity of Maryland, Department of Pharmaceutical Sciences, Baltimore, USA.ORCID 0000-0002-5274-4314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Norvir Materials and Methods: Results: Qualitatively, there was a large difference between Conclusion: Biopharmaceutic consideration of

Indexed as

absorptiondissolutionIVIVCNorvir® powderWagner-Nelson

Identifiers

PMID40916442
PMCPMC12415655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.